Podcast: Effect of molecular-targeted therapy on the progress and survival of people in the late stages of stomach cancer

Stomach cancer is the fifth most common cancer and third leading cause of cancer-related deaths worldwide. Molecular-targeted therapy is one of the newer treatments and a new Cochrane Review in July 2016 looks at the evidence from randomized trials. Lead author, Huan Song from the Karolinska Institutet in Sweden, tells us more in this Evidence Pod.

Share/Save